PerkinElmer to Use Orchid Tech to Develop, Sell SNP-Diagnostic Assays

genomeweb
360dx

PerkinElmer to Use Orchid Tech to Develop, Sell SNP-Diagnostic Assays

Jul 09, 2002

NEW YORK, July 9 - PerkinElmer will develop and sell fluorescence-based SNP-diagnostic assays gleaned from genotyping technology owned by Orchid Bioscience, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

ASHG: RNA Sequencing Can Improve Diagnostic Yield of Exome, Genome Tests
People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More
Low-Frequency Genetic Variations Contribute to Multiple Sclerosis Risk
In Brief This Week: Bruker, OneOme, Becton Dickinson, and More
ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results
Cowen Initiates Coverage of PacBio at Outperform

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Main menu